Preview Mode Links will not work in preview mode


Welcome to the Empowered Patient Podcast with Karen Jagoda.  This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients.  In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.

Popular Topics

  • Virtual and digital health
  • Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
  • Value-based healthcare 
  • Precision and stratified medicine
  • Integration of digital technology into existing workflow and procedures 
  • Next-generation immuno, cell, and gene therapies
  • Vaccines
  • Biomarkers, sequencing, and imaging
  • Rare diseases
  • MedTech and medical devices
  • Clinical trials
  • Addressing Social Determinants of Health
  • Treating chronic conditions like obesity and pain
  • Clinician and staff burnout

The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors. 


Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.

Empowered Patient Solutions

Dec 20, 2021

Kathy Lee-Sepsick is the President, CEO, and Founder of Femasys, and not looking at minor levels of improvement in women's healthcare, but products and technologies that change the standard of care.  With a focus on reproductive health, they are looking at infertility as well as a permanent birth control option for women.

Kathy explains, "So one of our major products is called FemVue. And what we did here is another example of what we're trying to do in these other product categories. We have developed a way to move an essential test for infertility diagnosis from radiology back to her GYN, utilizing ultrasound. So FemVue offers a saline and air contrast, or we call it bubbles, where those bubbles enable the evaluation and viewing of her fallopian tubes, which is suspect when a physician is evaluating all potential infertility factors."

"And at the same time, we are also advancing through clinical trial work, our FemBloc solution, which is our permanent birth control option for women. And both of those are delivered in an office environment. OBGYNs are performing the FemBloc procedure, and that's performed domestically as well in an active clinical trial."

@FemasysInc #ReproductiveHealth #WomensHealth #BirthControl #Infertility #FemBloc #FemVue

Download the transcript here